| Literature DB >> 34505460 |
Artur J Sabat1, Daniele Pantano1, Viktoria Akkerboom1, Erik Bathoorn1, Alexander W Friedrich1.
Abstract
The gold standard for the diagnosis of bacterial infections in clinical samples is based on culture tests that are time-consuming and labor-intense. For these reasons, an extraordinary effort has been made to identify biomarkers as the tools for sensitive, rapid and accurate identification of pathogenic microorganisms. Moreover, biomarkers have been tested to distinguish colonization from infection, monitor disease progression, determine the clinical status of patients or predict clinical outcomes. This mini-review describes Pseudomonas aeruginosa and Staphylococcus aureus biomarkers, which contribute to pathogenesis and have been used in culture-independent bacterial identification directly from patient samples.Entities:
Keywords: bacteremia; biomarkers; cystic fibrosis; endocarditis; osteomyelitis; virulence factors
Mesh:
Substances:
Year: 2021 PMID: 34505460 DOI: 10.1515/hsz-2021-0243
Source DB: PubMed Journal: Biol Chem ISSN: 1431-6730 Impact factor: 3.915